Regulatory frameworks directly influence sciatica treatment market growth, as agencies like the FDA and EMA rigorously evaluate device and therapy safety. Historically, approvals for spinal devices took 3–5 years, but recent guidance has streamlined processes. The FDA’s 2023 "Breakthrough Devices" program fast-tracks innovative MIS tools, reducing review timelines by 50%. The EMA...